Bronchiolitis obliterans

Seminars in Respiratory and Critical Care Medicine

Volumn 21, Issue 2, 2000, Pages 123-134

  Angel, Luis ^a   Homma, Arturo ^a   Levine, Stephanie M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bone marrow transplantation; Bronchiolitis obliterans; Constrictive bronchiolitis; Lung transplantation; Panbronchiolitis

Indexed keywords

BRONCHIOLITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; LUNG INFILTRATE; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; REVIEW;

EID: 0033912892     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9846     Document Type: Review

References (101)

1. Lange W. Ueber eine eigenthumliche Erkrankung der kleinen Bronchien und Bronchiolen (Bronchitis and Bronchiolitis obliterans) Dtsch Arch Klin Med 1901;342-364
2. King TE. Bronchiolitis. In: Schwarz MI, King TE, Jr (eds). Interstitial Lung Diseases. 3rd ed. Hamilton, Canada: BC Decker, 1998;645-684
3. Guerry-Force M, Muller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia and small airways disease. Am Rev Respir Dis 1987;135:705-712
4. King TE. Overview of bronchiolitis. Clin Chest Med 1993; 14:607-610
5. Wright J, Cagle P, Churg A, Colby TV, Myers J. Diseases of the small airways. Am Rev Respir Dis 1992;146:240-262
6. Colby TV. Bronchiolar pathology. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press, 1994;77-100
7. Muller NL, Staples CA, Miller RR. Bronchiolitis obliterans organizing pneumonia. CT features in 14 patients. AJR Am J Roentgenol 1990;154:983-987
8. Colby TV. Bronchiolitis: Pathologic considerations. Am J Clin Pathol 1998;109:101-109
9. Colby TV, Myers JL. The clinical and histologic spectrum of bronchiolitis obliterans including bronchiolitis obliterans organizing pneumonia (BOOP). Semin Respir Med 1992;13:119
10. Lynch DA. Imaging of small airways disease. Clin Chest Med 1993;14:623-634
11. Worthy SA, Muller NL. Small airways diseases. Radiol Clin North Am 1998;36:163-173
12. Muller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. State of the art review. Radiology 1995;196:3-12
13. Hwang J, Rim TS, Lee KS, et al. Bronchiolitis in adults: Pathology and Imaging. J Comput Assist Tomogr 1997; 21:913-919
14. Lentz D, Bergin CJ, Berry GJ, Stoehr C, Theodore J. Diagnosis of bronchiolitis obliterans in heart-lung transplantation patients. Importance of bronchial dilatation on CT. Am J Radiol 1992;59:463-467
15. Turton CW, William G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax 1981;36:805-810
16. Dorinsky PM, Davis WB, Lucas JG, Weiland JE, Gadek JE. Adult bronchiolitis. Evaluation by bronchoalveolar lavage and response to prednisone therapy. Chest 1985;88:58-63
17. Kindt GC, Weiland JE, Davis WB, Gadek JE, Dorinsky PM. Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989;140:483-492
18. St. John RC, Dorinsky PM. Cryptogenic bronchiolitis. Clin Chest Med 1993;14:667-675
19. Kraft M, Mortenson RL, Colby TV, Newman L, Waldron JA Jr, King TE Jr. Cryptogenic constrictive bronchiolitis. Am Rev Respir Dis 1993;148:1093-1011
20. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996;154:497-503
21. Tsang KWT, Ooi CGC, Ip MSM, et al. Clinical profiles of Chinese patients with diffuse panbronchiolitis. Thorax 1998;53:274-280
22. Park MH, Kim YW, Yoon HI, et al. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am J Respir Crit Care Med 1999;159:526-529
23. Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takakti F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1990;141:1459-1462
24. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 1983;83:63-69
25. Sugiyama Y. Diffuse panbronchiolitis. Clin Chest Med 1993; 14:765-772
26. Homma S, Kawabata M, Kishi K, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 1998;12: 444-452
27. Kudoh S, Axuma A, Yamamoti M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157:1829-1832
28. Ichikawa Y, Hotta M, Sumita S, Fujimoto K, Oizumi K. Reversible airway lesions in diffuse panbronchiolitis: Detection by high-resolution computed tomography. Chest 1995;107:120-125
29. Koyama H, Geddes DM: Erythromycin and diffuse panbronchiolitis. Thorax 1997;52:915-918
30. Kadota J-I Sakito O, Kohno S, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993;147:153-159
31. Commins BT, Raveney FJ, Jesson MW. Toxic gases in tower silos. Ann Occup Hyg 1971;14:275
32. Horvath EP, do Pico GA, Barbee RA, Dickie HA. Nitrogen dioxide-induced pulmonary disease. J Occup Med 1978;20:103-110
33. Fleming GM, Chester EH, Montenegro HD. Dysfunction of small airways following pulmonary injury due to nitrogen dioxide. Chest 1979;75:720-721
34. Zwemer FL, Pratt DS, May JJ. Silo filler's disease in New York State. Am Rev Respir Dis 1992;146:650-653
35. Douglas WW, Colby TV. Fume-related bronchiolitis obliterans. In: Epler GR, ed. Diseases of the Bronchioles. New York: Raven Press, 1994;187-213
36. Milne JEH. Nitrogen dioxide inhalation and bronchiolitis obliterans. J Occup Med 1969;11:538-547
37. Moskowitz RL, Lyons HA, Cottle HR. Silo-filler's disease: Clinical, physiologic and pathologic study of patient. Am J Med 1964;36:457-462
38. Becklake MR, Goldman HI, Bosnian AR. The long-term effects of exposure to nitrous fumes. Am Rev Tuberc 1957;76:398-409
39. Ramirez RJ, Dowell AR. Silo-filler's disease: Nitrogen dioxide-induced lung injury: long-term follow-up and review of the literature Ann Intern Med 1971;74:569-576
40. Jones GR, Proudfoot AT, Hall JI. Pulmonary effects of acute exposure to nitrous fumes. Thorax 1973;28:61-65
41. Douglas WW, Norman G, Hepper G, Colby TV. Silo-filler's disease. Mayo Clin Proc 1989;64:291-304
42. Wells AU, du Bois RM. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655-666
43. Epler G, Colby T, McLoud T, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985;312:152-158
44. Katzenstein A-L, Myers J, Prophet W, Corley LS III, Shin MS. Bronchiolitis obliterans an usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10:373-38
45. Rees JH, Woodhead MA, Sheppard MM, du Bois RMI. Rheumatoid arthritis and cryptogenic organizing pneumonia. Respir Med 1991;29:1582-1590
46. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131: 770-777
47. Epler GR, Snider GL, Gaensler EA, Cathcart ES, FitzGerald MX, Carrington CB. Bronchiolitis and bronchitis in connective tissue disease: A possible relationship to the use of penicillamine. JAMA 1979;242:528-532
48. Bégin R, Massé S, Cantin A, Menard HA, Bureau MA. Airway disease in a subset of nonsmoking rheumatoid patients: Characterization of the disease and evidence for an autoimmune pathogenesis. Am J Med 1982;72:743-750
49. Penny WJ, Knight RK, Rees AM, Thomas AL, Smith AP. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 1982;41:469-472
50. Van de Laar MAFJ, Westermann CJJ, Wagenaar SS, Dinant HJ. Beneficial effect of intravenous cyclophosphamide and oral prednisolone on d-penicillamine-associated bronchiolitis obliterans. Arthritis Rheum 1985;28:93-97
51. Van Thiel RJ, van der Burg S, Groote AD, Nossent GD, Wills SH. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Eur Respir J 1991;4:905-911
52. Fortoul TI, Cano-Valle F, Oliva E, Barrios E. Follicular bronchiolitis in association with connective tissue diseases. Lung 1985;163:305-314
53. Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol 1985;16:700-706
54. Bjerke RD, Tashkin DP, Clements PJ. Small airways in progressive systemic sclerosis (PSS). Am J Med 1979;66: 201-209
55. Weaver AL, Divertie MB, Titus JL. Pulmonary scleroderma. Dis Chest 1968;54:4-12
56. Davison AG, Epstein D. Relapsing organizing pneumonitis in a man with primary biliary cirrhosis, CREST syndrome, and chronic pancreatitis. Thorax 1983;38:316-317
57. Min JK, Hong YS, Park SH, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol 1997;24:2254-2257
58. Otsuka F, Amano T, Hashimoto N, Ogura T, Ishikawa A, Takahashi T. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med 1996;35:341-344
59. Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis: Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-733
60. Imasaki T, Yoshii A, Tanaka S, et al. Polymyositis and Sjogren's syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med 1996;35:231-235
61. Knoell KA, Hook M, Grice DP, Hendrix JD Jr. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J Am Acad Dermatol 1999; 40:328-330
62. Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients. Radiology 1999;210:333-338
63. Smith CB, Overall CJJ. Clinical and epidemiological clues to the diagnosis of respiratory infections. Radiol Clin North Am 1973;11:261-278
64. Penn CC, Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993;14:645-654
65. Philit F, Wiesendanger T, Archimbaud E, Mornex J-F, Brune J, Cordier J-F. Post-transplant obstructive lung disease ("bronchiolitis obliterans"): A clinical comparative study of bone marrrow and lung transplant patients. Eur Respir J 1995;8:551-558
66. Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: Clinical presentation and course. Ann Intern Med 1989; 111:368-376
67. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998;100:680-687
68. Paz HL, Crilley P, Pachefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992;101:775-778
69. Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987;107:648-656
70. Prince DS, Wingard JR, Saral R, Santos GW, Wise RA. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989;96:301-306
71. Crawford SW, Clark JG. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med 1993;14:741-750
72. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995;26:668-675
73. Thirman MJ, Devine SM, O'Toole K, et al. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation. Bone Marrow Transplant 1992;10:307-311
74. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant 1994;14:S19-S28
75. Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with a prior bone marrow transplant. Chest 1992;102:948
76. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation: Fifteenth official report-1998. J Heart Lung Transplant 1998;17:656-668
77. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997;155:789-819
78. Kroshus TJ, Kshettry VR, Savik K, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997;114: 195-202
79. Bando K, Paradis IL, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-14
80. Scott JP, Higgenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991;51:813-817
81. Bando K, Paradis IL, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995;110:4-14
82. Husain AN, Siddiqui MT, Holmea EW, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999;159:829-833
83. Sundaresan S, Mohanakumar T, Smith MA, et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998;65:648-653
84. Girgis RE, Tu I, Berry GJ, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996;15:1200-1208
85. Ross DJ, Marchevsky A, Kramer M, Kass RM. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplant 1997;16:832-838
86. Schulman LL, Weinberg AD, McGregor C, Galantowicz ME, Suciu-Foca NM, Itescu S. Mismatches at the GLA-DR and GLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med 1998;157: 1833-1837
87. Sundaresan RS, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA, Washington Universisty Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 1995;60:1341-1347
88. Keller CA, Cagle PT, Brown RW, Noon G, Frost AE. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 1995;107:973-980
89. Patterson GM, Wilson S, Whang JL, et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: A comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996;15:175-181
90. Ikonen T, Kivisaari L, Taskinen E, Piilonen A, Harjula ALJ. High-resolution CT in long-term follow-up after lung transplantation. Chest 1997;111:370-376
91. Leung An, Fisher K, Valentine V, et al. Bronchiolitis obliterans after lung transplantation. Chest 1998;113:365-370
92. International Society of Heart and Lung Transplantation, Cooper JD, Billlingham M, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993;12:713-716
93. Ross DJ, Lewis MI, Kramer M, Vo A, Kass RM. FK 506 'Rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. Chest 1997;112:1175-1183
94. Kesten S, Chaparro C, Scavuzza M, Gutierrez C. Tacrolimus as rescue therapy for bronchiolitis obliterans symdrome. J Heart Lung Transplant 1997;16:905-912
95. Whyte RI, Rossi SJ, Mulligan MS, et al. Mycophenolate inofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1997;64:945-948
96. Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995;60:580-585
97. Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J Heart Lung Transplant 1998;17:869-875
98. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996;15:371-383
99. Katzenstein A-L, Myers JL. Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:1301-1315
100. Myers JL, Veal CF, Shin MS, Katzenstein A-L. Respiratory bronchiolitis causing interstitial lung disease: A clinico-pathologic study of six cases. Am Rev Respir Dis 1987;135: 880-884
101. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373-1380